Founded in 1998, Wilex AG was one of the first products of the government-funded biotech splurge which kick-started the German biotech industry. But Wilex's product focus and strong cost-control distinguished it from the outset from most of its peers. Reflecting their country's research predilections, most German biotechs were built to offer discovery services based around their technology platforms.
Few investors or entrepreneurs had been through a full round of biotech investment cycles and they thus saw little reason...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?